Marker chromosome is a strong poor prognosis factor after allogeneic HSCT for adverse‐risk AML patients

Introduction Chromosome analysis is necessary for the risk classification of acute myeloid leukemia (AML). Marker chromosome (MC) is a fragmented chromosome whose origin cannot be identified from other chromosomes and originates from marked genomic instability. Although AML with MC (MC+) has a poor...

Ausführliche Beschreibung